Chengli Du
机构:First Affiliated Hospital Zhejiang University · ORCID:0000-0002-0128-9606
发表论文 38 篇 · 总被引 1400 次 · h-index 20
代表论文
- The Predictive Value of Tumor Mutation Burden on Efficacy of Immune Checkpoint Inhibitors in Cancers: A Systematic Review and Meta-Analysis (2019 · Frontiers in Oncology · 被引 146)
- VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification (2021 · Cancer Letters · 被引 70)
- Trends in cancer incidence and mortality rates in the United States from 1975 to 2016 (2020 · Annals of Translational Medicine · 被引 26)
- <p>Risk factors of postoperative pulmonary complications after minimally invasive anatomic resection for lung cancer</p> (2019 · Therapeutics and Clinical Risk Management · 被引 25)
- Identification of key pathways and core genes involved in atherosclerotic plaque progression (2021 · Annals of Translational Medicine · 被引 24)
- Bioinformatics analysis of differentially expressed genes in tumor and paracancerous tissues of patients with lung adenocarcinoma (2020 · Journal of Thoracic Disease · 被引 22)